Thursday, 25 September 2014

Epic Research Update : Aurobindo Pharma

Epic Update Aurobindo Pharma

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Amoxicillin for Oral Suspension USP 125mg/5mL and 250mg/5mL.



Real Time News & Trading Trends Keep Liking #EpicResearch




FacebookTwitterYouTubePinterestLinkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH


0 comments:

Post a Comment

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Online Project management